{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:27:28Z","timestamp":1794000448854,"version":"4.8.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82422023"],"award-info":[{"award-number":["82422023"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471288"],"award-info":[{"award-number":["82471288"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2506900"],"award-info":[{"award-number":["2023YFC2506900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC25069003"],"award-info":[{"award-number":["2023YFC25069003"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015733","name":"Lo-Hsu Medical Foundation Lotung Poh-Ai Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015733","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.diabres.2025.112270","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T19:11:04Z","timestamp":1747768264000},"page":"112270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Metformin vs. second-line therapy for delirium prevention in type 2 diabetes: A multinational study"],"prefix":"10.1016","volume":"225","author":[{"given":"Mingyang","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2294-9611","authenticated-orcid":false,"given":"Shuang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengrong","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5637-558X","authenticated-orcid":false,"given":"Szu-Yuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2025.112270_b0005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of type 2 diabetes - global burden of disease and forecasted trends","volume":"10","author":"Khan","year":"2020","journal-title":"J Epidemiol Glob Health"},{"key":"10.1016\/j.diabres.2025.112270_b0010","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2147\/CIA.S48926","article-title":"Type 2 diabetes as a risk factor for cognitive impairment: current insights","volume":"9","author":"Umegaki","year":"2014","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.diabres.2025.112270_b0015","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3233\/JAD-160114","article-title":"An Update on Type 2 Diabetes Mellitus as a Risk Factor for Dementia","volume":"53","author":"Li","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.diabres.2025.112270_b0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-019-04977-9","article-title":"Cognitive dysfunction in diabetes: how to implement emerging guidelines","volume":"63","author":"Biessels","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2025.112270_b0025","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/jamaneurol.2020.2273","article-title":"Association of delirium with long-term cognitive decline: a meta-analysis","volume":"77","author":"Goldberg","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.diabres.2025.112270_b0030","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1093\/brain\/aws190","article-title":"Delirium is a strong risk factor for dementia in the oldest-old: a population-based cohort study","volume":"135","author":"Davis","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.diabres.2025.112270_b0035","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/ageing\/afaa244","article-title":"Recurrent delirium over 12 months predicts dementia: results of the Delirium and Cognitive Impact in Dementia (DECIDE) study","volume":"50","author":"Richardson","year":"2021","journal-title":"Age Ageing"},{"key":"10.1016\/j.diabres.2025.112270_b0040","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-077634","article-title":"Delirium and incident dementia in hospital patients in New South Wales, Australia: retrospective cohort study","volume":"384","author":"Gordon","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2025.112270_b0045","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.exger.2012.07.014","article-title":"An update on type 2 diabetes, vascular dementia and Alzheimer's disease","volume":"47","author":"Exalto","year":"2012","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.diabres.2025.112270_b0050","doi-asserted-by":"crossref","first-page":"456","DOI":"10.2174\/1573399815666190129155654","article-title":"Pathophysiological mechanisms linking type 2 diabetes and dementia: review of evidence from clinical, translational and epidemiological research","volume":"15","author":"Bello-Chavolla","year":"2019","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.diabres.2025.112270_b0055","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3233\/JAD-2010-091687","article-title":"Type 2 diabetes, related conditions, in relation and dementia: an opportunity for prevention?","volume":"20","author":"Luchsinger","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.diabres.2025.112270_b0060","article-title":"Metformin use and risk of delirium in older adults with type 2 diabetes","author":"Sun","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2025.112270_b0065","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3233\/JAD-180263","article-title":"Metformin use associated with reduced risk of dementia in patients with diabetes: a systematic review and meta-analysis","volume":"65","author":"Campbell","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.diabres.2025.112270_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/ph15030312","article-title":"Metformin: a narrative review of its potential benefits for cardiovascular disease, cancer and dementia","volume":"15","author":"Top","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.diabres.2025.112270_b0075","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jcjd.2018.12.001","article-title":"Evaluation of healthy user effects with metformin and other oral antihyperglycemia medication users in adult patients with type 2 diabetes","volume":"43","author":"Eskin","year":"2019","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.diabres.2025.112270_b0080","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1200\/JCO.2015.63.3511","article-title":"Metformin use and survival of patients with pancreatic cancer: a cautionary lesson","volume":"34","author":"Chaiteerakij","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.diabres.2025.112270_b0085","first-page":"e35","article-title":"Second-line therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a systematic review and mixed-treatment comparison meta-analysis","volume":"5","author":"McIntosh","year":"2011","journal-title":"Open Med"},{"key":"10.1016\/j.diabres.2025.112270_b0090","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4172\/2155-6156.1000414","article-title":"Type 2 diabetes treatment recommendations update: Appropriate use of dipeptidyl peptidase-4 inhibitors","volume":"5","author":"Cornell","year":"2014","journal-title":"J Diabetes Metab"},{"key":"10.1016\/j.diabres.2025.112270_b0095","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s40200-024-01406-6","article-title":"Narrative review of data supporting alternate first-line therapies over metformin in type 2 diabetes","volume":"23","author":"Andraos","year":"2024","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.diabres.2025.112270_b0100","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.7326\/M21-2941","article-title":"First-line therapy for type 2 diabetes with sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists : a cost-effectiveness study","volume":"175","author":"Choi","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabres.2025.112270_b0105","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S2215-0366(21)00084-5","article-title":"6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records","volume":"8","author":"Taquet","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.diabres.2025.112270_b0110","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/apt.17570","article-title":"Efficacy of biologic and small molecule agents as second-line therapy after exposure to TNF inhibitors in patients with ulcerative colitis: A propensity-matched cohort study","volume":"58","author":"Kochhar","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.diabres.2025.112270_b0115","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.14309\/ajg.0000000000002947","article-title":"Comparative effectiveness of upadacitinib and tofacitinib in ulcerative colitis: a us propensity-matched cohort study","volume":"119","author":"Kochhar","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.diabres.2025.112270_b0120","series-title":"OHDSI Symposium","article-title":"Evaluating the performance of Austin\u2019s standardized difference heuristic in observational cohort studies with varying sample size","author":"Conover","year":"2021"},{"key":"10.1016\/j.diabres.2025.112270_b0125","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.2337\/dc16-2372","article-title":"Is it time to change the type 2 diabetes treatment paradigm? no! metformin should remain the foundation therapy for type 2 diabetes","volume":"40","author":"Inzucchi","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2025.112270_b0130","doi-asserted-by":"crossref","DOI":"10.1177\/2042018820980225","article-title":"Should metformin remain the first-line therapy for treatment of type 2 diabetes?","volume":"12","author":"Baker","year":"2021","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.diabres.2025.112270_b0135","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/CCM.0b013e3181e47be1","article-title":"Delirium as a predictor of long-term cognitive impairment in survivors of critical illness","volume":"38","author":"Girard","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.diabres.2025.112270_b0140","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","article-title":"Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications","volume":"14","author":"Biessels","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.diabres.2025.112270_b0145","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41582-022-00698-7","article-title":"The inter-relationship between delirium and dementia: the importance of delirium prevention","volume":"18","author":"Fong","year":"2022","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.diabres.2025.112270_b0150","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/oxfordjournals.aje.a115199","article-title":"Competing risks bias arising from an omitted risk factor","volume":"129","author":"Schatzkin","year":"1989","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.diabres.2025.112270_b0155","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9030660","article-title":"Association between the use of dipeptidyl peptidase 4 inhibitors and the risk of dementia among patients with type 2 diabetes in Taiwan","volume":"9","author":"Chen","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.diabres.2025.112270_b0160","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/MED.0000000000000783","article-title":"Type 2 diabetes mellitus and cognitive function: understanding the connections","volume":"30","author":"Dao","year":"2023","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.diabres.2025.112270_b0165","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3233\/ADR-220002","article-title":"Metformin and dementia risk: a systematic review with respect to time related biases","volume":"6","author":"Dai","year":"2022","journal-title":"J Alzheimers Dis Rep"},{"key":"10.1016\/j.diabres.2025.112270_b0170","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1111\/jgs.18306","article-title":"Newer glucose-lowering drugs and risk of dementia: A systematic review and meta-analysis of observational studies","volume":"71","author":"Tang","year":"2023","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.diabres.2025.112270_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113686","article-title":"Mechanism of metformin regulation in central nervous system: Progression and future perspectives","volume":"156","author":"Cao","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.diabres.2025.112270_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104593","article-title":"Emerging neuroprotective effect of metformin in Parkinson's disease: A molecular crosstalk","volume":"152","author":"Paudel","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.diabres.2025.112270_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.149874","article-title":"Metformin alters dendrite development and synaptic plasticity in rat cortical neurons","volume":"710","author":"Oner","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.diabres.2025.112270_b0190","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.yexcr.2016.08.013","article-title":"Metformin activation of AMPK-dependent pathways is neuroprotective in human neural stem cells against Amyloid-beta-induced mitochondrial dysfunction","volume":"347","author":"Chiang","year":"2016","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.diabres.2025.112270_b0195","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/bies.200900003","article-title":"Expanding roles for AMP-activated protein kinase in neuronal survival and autophagy","volume":"31","author":"Poels","year":"2009","journal-title":"Bioessays"},{"key":"10.1016\/j.diabres.2025.112270_b0200","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2174\/0929867322666150227153308","article-title":"Mechanisms of neurodegeration in type 2 diabetes and the neuroprotective potential of dipeptidyl peptidase 4 inhibitors","volume":"22","author":"Matteucci","year":"2015","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.diabres.2025.112270_b0205","doi-asserted-by":"crossref","first-page":"753","DOI":"10.4103\/2230-8210.141319","article-title":"Dipeptidyl peptidase-4 inhibitors: Novel mechanism of actions","volume":"18","author":"Singh","year":"2014","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.diabres.2025.112270_b0210","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/HCO.0000000000000673","article-title":"Review of cardiovascular outcomes trials of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists","volume":"34","author":"North","year":"2019","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.diabres.2025.112270_b0215","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.coph.2020.10.018","article-title":"Metformin: still the sweet spot for CV protection in diabetes?","volume":"54","author":"Rena","year":"2020","journal-title":"Curr Opin Pharmacol"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725002840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725002840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:07:51Z","timestamp":1778566071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822725002840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":43,"alternative-id":["S0168822725002840"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112270","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin vs. second-line therapy for delirium prevention in type 2 diabetes: A multinational study","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112270","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112270"}}